Relestat 0.5mg Eye Drops

    Relestat 0.5mg Eye Drops

    S2
    PDF Leaflet Revision Date: 21 April 2023

    API: Epinastine | Company: AbbVie

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Short-term treatment of seasonal allergic conjunctivitis symptoms.

    Dosage (summary)

    One drop in each affected eye twice daily.

    Onset of Action / Duration

    Onset: 2 hours, Duration: at least 8 hours

    Special Populations

    • Elderly
    • Hepatic impairment
    • Renal impairment

    Pregnancy & Breastfeeding

    Not established as safe in pregnancy or lactation.

    Contraindications

    • Hypersensitivity to epinastine or excipients

    Common side effects

    • Burning sensation in eye
    • Eye irritation
    • Headache

    Counselling Points

    • Do not wear contact lenses during use
    • Wait 15 mins after instillation before inserting lenses
    • May cause transient blurring of vision

    Serious warnings

    • Topical use only
    • Contains benzalkonium chloride
    • Caution with prolonged use
    Important Disclaimer

    The Relestat 0.5mg Eye Drops professional information leaflet below is the property of AbbVie and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn